Gilead Sciences (GILD) was climbing in late trading on its better-than-expected fourth quarter. Gilead said it earned $2.43 a share on revenue of $7.31 billion. Analysts were looking for earnings of $2.16 on revenue of $6.67 billion. It also announced a $15 billion share repurchase program. As for …